Aclarion welcomes advocate health as clarity trial site

Advocate health actively participates in research studies and is an innovator in technology, including spine the clarity trial is designed to demonstrate nociscan's ability to improve surgical outcomes for chronic low back pain nociscan aims to become the gold standard in identifying sources of low back pain through mr spectroscopy (mrs) and augmented intelligence (ai) broomfield, colo., may 05, 2025 (globe newswire) -- aclarion, inc., (“aclarion” or the “company”) (nasdaq: acon, aconw), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (ai) algorithms to help physicians identify the location of chronic low back pain, today announced the addition of advocate aurora research institute, part of advocate health, as a clarity (chronic low back pain randomized independent trial study) site.
ACON Ratings Summary
ACON Quant Ranking